| # | Compound | Evidence | EU Status | Last reviewed |
|---|---|---|---|---|
| 001. | Semaglutide INN · semaglutidum · C₁₈₇H₂₉₁N₄₅O₅₉ · MW 4113.6 GLP-1 receptor agonist · once-weekly subcutaneous | S | AUTHORISED | 18 MAY 2026 |
| 002. | Tirzepatide INN · tirzepatidum · C₂₂₅H₃₄₈N₄₈O₆₈ · MW 4813.5 Dual GIP / GLP-1 receptor agonist · once-weekly subcutaneous | S | AUTHORISED | 18 MAY 2026 |
| 003. | Tesamorelin INN · tesamorelinum Synthetic GHRH analogue · stimulates pituitary GH release · daily subcutaneous | A | AUTHORISED | 18 MAY 2026 |
| 004. | Cagrilintide INN · cagrilintidum Long-acting amylin receptor agonist · weekly subcutaneous · investigational | B | NOT AUTHORISED | 18 MAY 2026 |
| 005. | Mazdutide INN · mazdutidum Dual GLP-1 / glucagon receptor agonist · weekly subcutaneous · investigational | B | NOT AUTHORISED | 18 MAY 2026 |
| 006. | Retatrutide INN · retatrutidum Triple GLP-1 / GIP / glucagon receptor agonist · weekly subcutaneous · investigational | B | NOT AUTHORISED | 18 MAY 2026 |
| 007. | Survodutide INN · survodutidum Dual GLP-1 / glucagon receptor agonist · weekly subcutaneous · investigational | B | NOT AUTHORISED | 18 MAY 2026 |
| 008. | Cotadutide INN · cotadutidum Dual GLP-1 / glucagon receptor agonist · investigational, development paused | C | NOT AUTHORISED | 18 MAY 2026 |
| 009. | 5-Amino-1MQ NNMT (nicotinamide N-methyltransferase) inhibitor · investigational metabolic modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 010. | AOD-9604 Synthetic fragment of HGH (residues 176-191) · purported lipolytic agent | D | NOT AUTHORISED | 18 MAY 2026 |
| 011. | Pancragen Short peptide bioregulator · claimed pancreatic tissue modulator | D | NOT AUTHORISED | 18 MAY 2026 |
| 012. | SLU-PP-332 ERR (estrogen-related receptor) pan-agonist · investigational exercise-mimetic | D | NOT AUTHORISED | 18 MAY 2026 |